0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

PSA Screening and Prostate Cancer Incidence-Reply

Steven J. Jacobsen, MD, PhD; Slavica K. Katusic, MD; Erik J. Bergstralh, MS; George G. Klee, MD, PhD; Christopher G. Chute, MD, DrPh; Michael M. Lieber, MD; Joseph E. Oesterling, MD
JAMA. 1996;275(15):1155-1156. doi:10.1001/jama.1996.03530390021016.
Text Size: A A A
Published online

In Reply.  —We agree with the comments from Drs Rhoads and Mills regarding the lack of data in our article that demonstrate a reduction in morbidity and mortality from prostate cancer. However, their assertion that the transient increase in incidence of prostate caner will not be short lived is perhaps too globally stated. The duration of the increase is a function of the incidence and prevalence of cancer and it also depends on the degree of penetration of screening programs. In Olmsted County, Minnesota, where the rates of serum PSA testing have reached 50% of the population of men in their 60s, the transient increase will be much shorter lived than in areas where only 10% to 20% of the population is screened each year.Rhoads and Mills are also correct in focusing on mortality as one of the ultimate measures of efficacy of the screening program. We hope that

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();